Provided by Tiger Trade Technology Pte. Ltd.

Centessa Pharmaceuticals plc

23.55
+0.02000.08%
Post-market: 23.550.00000.00%18:02 EST
Volume:451.57K
Turnover:10.69M
Market Cap:3.44B
PE:-12.93
High:24.03
Open:23.76
Low:23.46
Close:23.53
52wk High:30.58
52wk Low:9.60
Shares:146.00M
Float Shares:97.13M
Volume Ratio:0.31
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8212
EPS(LYR):-2.0595
ROE:-60.62%
ROA:-25.26%
PB:11.40
PE(LYR):-11.43

Loading ...

Centessa Pharmaceuticals Chief Legal Officer Iqbal J. Hussain Reports Disposal of Common Shares

Reuters
·
Feb 04

Centessa Pharmaceuticals nimmt an mehreren internationalen Investorenkonferenzen teil

Reuters
·
Feb 03

Centessa Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Jan 29

Truist Financial Remains a Buy on Centessa Pharmaceuticals (CNTA)

TIPRANKS
·
Jan 29

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lexicon Pharmaceuticals (LXRX) and Alkermes (ALKS)

TIPRANKS
·
Jan 16

Centessa Pharmaceuticals (CNTA) Gets a Buy from Leerink Partners

TIPRANKS
·
Jan 14

Nxera Pharma Receives US$3.6 Million Milestone Payment from Centessa

Reuters
·
Jan 13

Can ORX750’s Sleep-Disorder Promise Redefine Centessa Pharmaceuticals’ (CNTA) Competitive Positioning in Neurology?

Simply Wall St.
·
Jan 10

Centessa Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Jan 09

Centessa price target raised to $33 from $30 at Truist

TIPRANKS
·
Jan 08

Centessa Pharmaceuticals Issues Amended UK Employment Agreement

Reuters
·
Jan 07

Centessa Pharmaceuticals Is Maintained at Buy by Chardan Capital

Dow Jones
·
Jan 02

Centessa Pharmaceuticals PLC - Appoints Mario Alberto Accardi As CEO

Reuters
·
Dec 11, 2025

Centessa Pharmaceuticals Names Mario Alberto Accardi CEO

MT Newswires Live
·
Dec 11, 2025

Press Release: Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications

Dow Jones
·
Dec 11, 2025

Centessa Pharmaceuticals President Mario Alberto Accardi Reports Disposal of Common Shares

Reuters
·
Dec 10, 2025

Mario Alberto Accardi, President of Orexin Program, sells common shares of Centessa Pharmaceuticals plc

Reuters
·
Dec 09, 2025

13D Filings -- Barrons.com

Dow Jones
·
Dec 06, 2025

Centessa Pharmaceuticals Plc : B. Riley Raises Target Price to $42 From $33

THOMSON REUTERS
·
Dec 01, 2025

Centessa Pharmaceuticals Announces Pricing Of $250,000,000 Public Offering Of American Depositary Shares

Reuters
·
Nov 20, 2025